Denis Chem Lab Limited, a pharmaceutical company, announced strong Q1 FY2026 results. Net profit increased by 19% to Rs 247.50 crore, while revenue from operations grew 4.9% to Rs 4,327.59 crore. Earnings per share rose to Rs 1.78 from Rs 1.50 in the previous year. The company demonstrated effective cost management despite increased material costs. Managing Director Himanshu C. Patel highlighted the company's resilience and operational strength. Auditors Shah & Shah Associates issued an unmodified opinion on the financial results.